Peer Reviewed
Feature Article Rheumatology

An overview of systemic lupus erythematosus

Sean O’neill, Leslie Schrieber
Abstract
Systemic lupus erythematosus is a multisystem disease with manifestations ranging from trivial to life threatening. Managing the late manifestations such as premature cardiovascular disease and minimising the adverse effects of treatment have become a growing challenge.
Key Points
  • The diagnosis of systemic lupus erythematosus (SLE) can be simple, but at times the disorder can masquerade as other conditions such as infection or malignancy.
  • A positive antinuclear antibody (ANA) test is not diagnostic alone for SLE; it is one of the 11 criteria, four of which are required for a definite diagnosis.
  • It is important that care is shared between GPs and appropriate specialists because SLE is uncommon and has a very variable clinical expression. Patient education and support are important in achieving the best long-term outcome.
  • Management of SLE must be tailored to the individual patient, reserving immunosuppression for those with life-threatening organ involvement.
  • As survival of patients with SLE has improved, managing the late manifestations of the disease such as premature cardiovascular disease and minimising the adverse effects of treatment has become a growing challenge.
Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?